Related Experiment Video
Updated: Feb 8, 2026

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
Uropathogen Resistance and Antibiotic Prophylaxis: A Meta-analysis
Rachel E Selekman1, Daniel J Shapiro2, John Boscardin3
1Departments of Urology.
Insights
Antibiotic prophylaxis for children with vesicoureteral reflux significantly increases the risk of multidrug-resistant urinary tract infections (UTIs). This finding impacts the assessment of prophylaxis benefits and treatment strategies for recurrent UTIs.
Area of Science:
- Pediatric Nephrology
- Infectious Diseases
- Clinical Pharmacy
Background:
- Limited data exist on uropathogen resistance in randomized controlled trials (RCTs) for urinary tract infection (UTI) prevention.
- Antibiotic prophylaxis is a common strategy for preventing recurrent UTIs in children with vesicoureteral reflux (VUR).
Purpose of the Study:
- To assess the impact of antibiotic prophylaxis on the development of multidrug-resistant (MDR) first recurrent UTIs in children with VUR.
Main Methods:
- Systematic review and meta-analysis of RCTs involving pediatric patients (≤18 years) with VUR receiving continuous antibiotic prophylaxis.
- Data extraction and quality assessment followed PRISMA guidelines.
- Mixed-effects logistic regression was used for adjusted meta-analyses.
Main Results:
- Patients receiving prophylaxis were significantly more likely to develop MDR infections (33% vs. 6%, P < .001).
- Prophylaxis recipients had 6.4 times the odds of developing MDR infections (95% CI: 2.7-15.6).
- One MDR infection occurred for every 21 children treated with prophylaxis.
Conclusions:
- Antibiotic prophylaxis for VUR increases the risk of multidrug resistance in recurrent UTIs.
- This necessitates a re-evaluation of the risk-benefit profile of prophylaxis.
- Findings have implications for empirical treatment selection in breakthrough infections.
Context:
Limited data exist regarding uropathogen resistance in randomized controlled trials of urinary tract infection (UTI) prevention and antibiotic prophylaxis.
Objective:
To assess the effect of prophylaxis on developing a multidrug-resistant first recurrent UTI among children with vesicoureteral reflux.
Data Sources:
Cochrane Kidney and Transplant Specialized Register through May 25, 2017.
Study Selection:
Randomized controlled trials of patients ≤18 years of age with a history of vesicoureteral reflux being treated with continuous antibiotic prophylaxis compared with no treatment or placebo with available antibiotic sensitivity profiles.
Data Extraction:
Two independent observers abstracted data and assessed quality and validity per Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Adjusted meta-analyses were performed by using a mixed-effects logistic regression model.
Results:
One thousand two hundred and ninety-nine patients contributed 224 UTIs. Patients treated with prophylaxis were more likely to have a multidrug-resistant infection (33% vs 6%, P < .001) and were more likely to receive broad-spectrum antibiotics (68% vs 49%, P = .004). Those receiving prophylaxis had 6.4 times the odds (95% confidence interval: 2.7-15.6) of developing a multidrug-resistant infection. One multidrug-resistant infection would develop for every 21 reflux patients treated with prophylaxis.
Limitations:
Variables that may contribute to resistance such as medication adherence and antibiotic exposure for other illnesses could not be evaluated.
Conclusions:
Prophylaxis increases the risk of multidrug resistance among recurrent infections. This has important implications in the risk-benefit assessment of prophylaxis as a management strategy and in the selection of empirical treatment of breakthrough infections in prophylaxis patients.
Related Concept Videos
Development of Antibiotic Resistance
Antibiotic Selection
Directing Effect of Substituents: meta-Directing Groups
Resistivity
Resistance
Equivalent Resistance

